Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center, Shanghai, China.
Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center, Shanghai, China; Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
Ophthalmology. 2017 Mar;124(3):326-335. doi: 10.1016/j.ophtha.2016.10.041. Epub 2016 Dec 16.
To calculate crystalline lens power and to determine the relationship between ocular biometry and diabetic retinopathy (DR) in an adult population with type 2 diabetes mellitus (T2DM).
Cross-sectional, population-based study.
Patients with T2DM from the Beixinjing community, Changning district, Shanghai.
Random clustering sampling was used to identify adults with T2DM in the Beixinjing community. Spherical equivalent (SE) was determined by subjective refraction that achieved the best corrected vision. Axial length (AL), corneal power (CP), and anterior chamber depth (ACD) were measured using the IOLMaster. Diabetic retinopathy and diabetic macular edema (DME) were assessed according to the international DR classification.
The crystalline lens power was calculated using the Bennett-Rabbetts formula. The AL-to-corneal radius ratio (AL/CR ratio) was defined as the axial length divided by the mean corneal radius of curvature.
A total of 4011 eyes of 2057 subjects with T2DM were included in the analysis. In multivariate logistic models adjusting for age, sex, duration of diabetes, glycosylated hemoglobin A1c, serum creatinine, body mass index, systolic blood pressure, and cataract, after categorizing values into quartiles, there were trend associations between lens power and any DR (P = 0.01), between AL/CR ratio and any DR (P = 0.02), and between AL and any DR (P = 0.03), between lens power and moderate DR (P = 0.02), and between AL and moderate DR (P = 0.02); eyes with higher AL/CR ratio were less likely to have any DR (odds ratio [OR], 0.43; 95% confidence interval [CI], 0.24-0.78; P = 0.01 per 1 increase) and moderate DR (OR, 0.44; 95% CI, 0.21-0.93; P = 0.03 per 1 increase), eyes with longer AL were less likely to have any DR (OR, 0.88; 95% CI, 0.81-0.95; P = 0.002 per millimeter increase) or moderate DR (OR, 0.89; 95% CI, 0.80-0.98; P = 0.02 per millimeter increase), and eyes with higher SE were more likely to have any DR (OR, 1.08; 95% CI, 1.03-1.13; P = 0.003 per diopter increase).
In persons with T2DM, lens power, AL/CR ratio, and AL were associated with the presence of any DR and moderate DR. These findings suggested that globe elongation plays a major role in protective effects against DR, with contributions from lens power and other refractive components.
计算晶状体的屈光力,并确定 2 型糖尿病(T2DM)患者的眼生物测量学与糖尿病视网膜病变(DR)之间的关系。
横断面、基于人群的研究。
来自上海长宁区北新泾社区的 T2DM 患者。
采用随机聚类抽样方法,在北新泾社区中确定 T2DM 成人患者。通过达到最佳矫正视力的主观屈光确定等效球镜(SE)。使用 IOLMaster 测量眼轴(AL)、角膜屈光力(CP)和前房深度(ACD)。根据国际 DR 分类评估 DR 和糖尿病性黄斑水肿(DME)。
使用 Bennett-Rabbetts 公式计算晶状体屈光力。将眼轴长度与平均角膜曲率半径的比值定义为 AL/CR 比值。
共纳入 4011 只眼、2057 例 T2DM 患者的数据分析。在调整年龄、性别、糖尿病病程、糖化血红蛋白 A1c、血清肌酐、体重指数、收缩压和白内障后,在多元逻辑回归模型中,将值分为四组后,晶状体屈光力与任何 DR(P=0.01)、AL/CR 比值与任何 DR(P=0.02)、AL 与任何 DR(P=0.03)、晶状体屈光力与中度 DR(P=0.02)和 AL 与中度 DR(P=0.02)之间均存在趋势关联;AL/CR 比值较高的眼睛发生任何 DR(比值比[OR],0.43;95%置信区间[CI],0.24-0.78;P=0.01 每增加 1)和中度 DR(OR,0.44;95%CI,0.21-0.93;P=0.03 每增加 1)的可能性较低;AL 较长的眼睛发生任何 DR(OR,0.88;95%CI,0.81-0.95;P=0.002 每毫米增加)或中度 DR(OR,0.89;95%CI,0.80-0.98;P=0.02 每毫米增加)的可能性较低;SE 较高的眼睛发生任何 DR(OR,1.08;95%CI,1.03-1.13;P=0.003 每增加 1 屈光度)的可能性较高。
在 T2DM 患者中,晶状体屈光力、AL/CR 比值和 AL 与任何 DR 和中度 DR 的发生有关。这些发现表明眼球伸长在预防 DR 方面发挥了主要作用,晶状体屈光力和其他屈光成分也发挥了作用。